StockData
Ascentage Pharma Group International logo

Ascentage Pharma Group International (AAPG) stock

AAPGNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 29, 2026Score 3/30
$13.01−0.13 (-0.97%)

Close on Nov 18, 2026Market cap $1.21BP/E –Yield –

Ascentage Pharma Group International price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Ascentage Pharma Group International's price to sales ratio was 16.3× on Nov 11, 2026, against 18.5× a year earlier.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202616.3×+1.5
2025Dec 31, 202514.7×–

More Ascentage Pharma Group International figures

See a number that looks wrong?